Trials / Completed
CompletedNCT00150332
Linezolid for the Treatment of Infections Caused by Methicillin Resistant Staphylococcus Aureus in Japan
Linezolid (PNU-10766/PNU10766SS) in the Treatment of MRSA Infections in Patients Whose Conventional Therapy Has Failed, or Who Are Intolerant to Conventional Therapy; an Open-label, Multi-center Trial
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
Use of linezolid in patients with methicillin-resistant Staphylococcus aureus infections in Japan
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | linezolid |
Timeline
- Start date
- 2003-01-01
- Completion
- 2006-01-01
- First posted
- 2005-09-08
- Last updated
- 2011-05-10
Locations
20 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00150332. Inclusion in this directory is not an endorsement.